# Loyalfordogs

**Canonical:** https://apis.io/providers/loyalfordogs/  
**Website:** https://loyalfordogs.com/  
**APIs profiled:** 0

Loyal (Cellular Longevity, Inc., loyalfordogs.com redirects to loyal.com) is a San Francisco biotech developing longevity drugs for dogs that target the underlying processes of aging to extend healthy lifespan in senior dogs. Its lead candidate, LOY-002, targets metabolic dysfunction in dogs aged ten and older and is progressing through FDA approval. The company serves veterinary professionals and dog owners with clinical and care resources and runs clinical trials; it publishes no developer API, documentation, SDKs, or public code repositories. Surfaced as a portfolio company of Khosla Ventures and added to the API Evangelist network.

## Kin Score — 3.3 / 100 (minimal)

Scored 2026-08-20 under rubric 0.12.0. Trend: flat (+0.0 from 3.3).

| Facet | Score |
|---|---|
| Discoverability | 50.0 |
| Contract Quality | 0.0 |
| Governance | 0.0 |
| Contract Governance | 0.0 |
| Operational Transparency | 0.0 |
| Developer Ergonomics | 0.0 |
| Commercial Clarity | 0.0 |
| Access Clarity | 0.0 |

Regulatory layer — **Health**: 7.5 (matched via tags).

## Agent readiness — 0.0 (human-only)

| Dimension | Value |
|---|---|
| Spec Presence | no |
| Agentic Access | no |
| Reversibility Documented | no |
| MCP Server | no |
| Auth Clarity | no |
| Idempotency | no |
| Error Semantics | no |
| OpenAPI Examples | no |
| Rate Limit Signal | no |
| Event Surface Described | no |
| Agent Skills | no |
| Well Known Catalog | no |
| Consent Identity | no |
| Agent Card | no |
| Dry Run Mode | no |

## Access

Unknown — onboarding: unknown, pricing: unknown, trial: no (confidence: low).

## Security (1)

- **Loyalfordogs Domain Security** — TLSv1.2 · HSTS

## Tags

Company, Biotechnology, Pharmaceuticals, Animal Health, Veterinary, Longevity, Healthcare

---

Profiled by [API Evangelist](https://apievangelist.com) and published on [APIs.io](https://apis.io/providers/loyalfordogs/). Scores are computed from the provider's own public artifacts under a published rubric.